Last quarter (Q3 2023), Crinetics Pharmaceuticals's total revenue was $346.00K, a decrease of -24.45% from the same quarter last year. In Q3, Crinetics Pharmaceuticals's net income was $-57.46M. See Crinetics Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ -15.00K	$ 4.74M	-	$ 0.00	$ 1.19M	$ 2.43M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 585.00K	$ 4.74M	-	-	-	-
Operating Expense	$ 115.70M	$ 172.62M	$ 108.78M	$ 74.95M	$ 55.02M	$ 31.14M
Operating Income	$ -211.64M	$ -167.88M	$ -108.78M	$ -74.95M	$ -53.83M	$ -28.71M
Net Non Operating Interest Income Expense	$ 8.57M	$ 4.32M	$ 157.00K	$ 991.00K	$ 3.46M	$ 1.75M
Other Income Expense	$ -3.60M	$ 353.00K	$ -982.00K	$ 150.00K	$ -50.00K	$ -153.00K
Pretax Income	$ -199.48M	$ -163.92M	$ -107.64M	$ -73.81M	$ -50.42M	$ -27.11M
Tax Provision	-	$ -1.45M	$ -1.09M	-	-	-
Earnings From Equity Interest Net Of Tax	-	$ -1.01M	-	-	-	-
Net Income Common Stockholders	$ -199.48M	$ -163.92M	$ -107.64M	$ -73.81M	$ -50.42M	$ -27.11M
Basic EPS	$ -4.36	$ -3.15	$ -2.80	$ -2.42	$ -2.09	$ -2.23
Diluted EPS	$ -3.63	$ -3.15	$ -2.80	$ -2.42	$ -2.09	$ -2.23
Basic Average Shares	$ 216.97M	$ 51.98M	$ 38.44M	$ 30.45M	$ 24.18M	$ 12.14M
Diluted Average Shares	$ 216.97M	$ 51.98M	$ 38.44M	$ 30.45M	$ 24.18M	$ 12.14M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 115.70M	$ 172.62M	$ 108.78M	$ 74.95M	$ 55.02M	$ 31.14M
Net Income From Continuing And Discontinued Operation	$ -199.48M	$ -163.92M	$ -107.64M	$ -73.81M	$ -50.42M	$ -27.11M
Normalized Income	$ -45.39M	$ -166.02M	-	$ -73.81M	$ -50.42M	$ -27.11M
Interest Expense	-	-	-	-	-	$ 0.00
EBIT	$ -201.39M	$ -164.57M	$ -107.64M	$ -74.95M	$ -53.83M	$ -28.71M
EBITDA	$ -203.31M	$ -163.56M	$ -106.30M	$ -74.00M	$ -52.95M	$ -28.24M

Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing